VAERS Reports UJ93AA

VAERS 2576898

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge uj93aa

schwer

Staat: MO
Alter: 23,0
Geschlecht: M
Eingang: 06.02.2023
Impfdatum: 06.02.2023
Beginn: 06.02.2023
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Pallor Presyncope Syncope Tremor

Symptomtext

Patient received both the Boostrix and Fluzone Quad vaccinations administered by pharmacy intern. Sat in a chair outside the pharmacy for his 15 minute observation. after less than a minute, his friend yelled for help as he was visibly fainting and very pale. I responded to help the patient and lowered him flat on the floor and elevated his feet. He came to and started responding within 30 seconds to 1 minute after I got out to him. While I was taking care of him, my other pharmacist called EMS. I started conversing with him and he was coherent. He reported feeling a bit shaky still. I explained that it was likely a vasovagal response and that I would stay with him until he felt better. EMS arrived After about 5 minutes and took vitals, which were normal. Patient opted to decline ambulance transportation. They did decide to go to urgent care to be seen after the event. When patient left he had his color back and was conversing normally and his shakes had gone away. 15-20 minutes after event patient felt back to normal and left the store.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568326

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ93AA

gering

Staat: -
Alter: 9,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 04.01.2023
Beginn: 04.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; Initial information received on 17-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 9 years old female patient to whom influenza quadrivalent recombinant vaccine [Flublok] inadvertently ordered, staff administered to six patients, should have been influenza USP trival A-B subvirion no preservative vaccine [Fluzone] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided. On 04-Jan-2023, the patient received 0.5 ml dose of suspect influenza quadrivalent recombinant vaccine (lot UJ93AA; strength, formulation, frequency, expiry date: unknown) via intramuscular route in unknown administration site for prophylactic vaccination. On 04-JAN-2023 the flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event (wrong product administered) (product administered to patient of inappropriate age) (latency: same day). It is unknown if there were lab data/results available Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567297

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ93AA

gering

Staat: -
Alter: 11,0
Geschlecht: F
Eingang: 25.01.2023
Impfdatum: 04.01.2023
Beginn: 04.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Medication error No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; Initial information received on 17-Jan-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 11 years old female patient whom influenza quadrivalent recombinant vaccine [Flublok] inadvertently ordered, staff administered to six patients, should have been influenza trival A-B subvirion no preservative vaccine [Fluzone] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided. On 04-Jan-2023, the patient received 0.5 ml dose of suspect influenza quadrivalent recombinant vaccine (lot UJ93AA; strength, formulation, frequency, expiry date: unknown) via intramuscular route in unknown administration site for prophylactic vaccination. On 04-JAN-2023 the flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event (wrong product administered) (product administered to patient of inappropriate age) (latency: on same day). It is unknown if there were lab data/results available Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567296

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ93AA

gering

Staat: -
Alter: 11,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 04.01.2023
Beginn: 04.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Medication error No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; Initial information received on 17-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 11 years old male patient to whom influenza quadrivalent recombinant vaccine [Flublok] inadvertently ordered, staff administered to six patients, should have been influenza trival A-B subvirion no preservative vaccine [Fluzone] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided. On 04-Jan-2023, the patient received 0.5 ml dose of suspect influenza quadrivalent recombinant vaccine (lot UJ93AA; strength, formulation, frequency, expiry date: unknown) via intramuscular route in unknown administration site for prophylactic vaccination. On 04-JAN-2023 the flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event (wrong product administered) (product administered to patient of inappropriate age) (latency:same day). It is unknown if there were lab data/results available Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567295

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ93AA

gering

Staat: MI
Alter: 6,0
Geschlecht: F
Eingang: 25.01.2023
Impfdatum: 04.01.2023
Beginn: 04.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Medication error No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event; Initial information was received from on 17-Jan-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 6 years old female patient to whom influenza quadrivalent recombinant vaccine [Flublok] inadvertently ordered, staff administered to six patients, should have been influenza trival A-B subvirion no preservative vaccine [Fluzone] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided. On 04-Jan-2023, the patient received 0.5 ml dose of suspect influenza quadrivalent recombinant vaccine (lot UJ93AA; strength, formulation, frequency, expiry date: unknown) via intramuscular route in unknown administration site for prophylactic vaccination. On 04-JAN-2023 the flublok inadvertently ordered, staff administered to six patients, should have been fluzone with no adverse event (wrong product administered) (product administered to patient of inappropriate age) (latency: on same day). It is unknown if there were lab data/results available Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -